An animal that could offer hope in the fight against schizophrenia has been identified.

According to a new study, llamas may be a beacon of hope in the treatment of schizophrenia. Schizophrenia, a serious brain disease, causes individuals to perceive reality abnormally. However, this domesticated, woolly animal of South American origin may contribute to the treatment of this disease. French researchers announced this week that they have engineered a small piece of llama antibodies, proteins that help protect the immune system, known as a “nanobody.” This nanobody can activate a neurotransmitter that regulates neural activity in the brain. Neurotransmitters are chemical molecules that carry messages between nerve cells. IT HAS ALSO BEEN EFFECTIVE IN COVID AND SARS In the past, llama antibodies have also been shown to be effective in combating Covid and other SARS-like viruses. Scientists at the Institute of Functional Genomics found that when they injected this molecule intravenously or intramuscularly, it was able to cross the blood-brain barrier and reach brain receptors. This barrier is a tight layer of cells that protects the brain from harmful substances.

When the researchers examined the effects of the nanobodies in two separate tests on mice , they found that the observed cognitive deficits improved. Improvement in cognitive function was observed with just a single injection, and this effect was reported to last for a week. Clinical studies are now underway to determine whether these findings offer a new avenue for treating schizophrenia.

HOW DOES SCHIZOPHRENIA OCCURR? The exact cause of schizophrenia, a chronic illness, is unknown. However, the World Health Organization states that the interaction of genetics and environmental factors may be influential. The exact prevalence of schizophrenia is difficult to measure. While schizophrenia can occur at any age, it is typically diagnosed between the ages of 16 and 30. Symptoms vary from person to person. There is no definitive cure for the disease, but it can be managed with antipsychotic medications, therapy, and personal coping strategies. This information is shared by the National Alliance on Mental Illness. The study authors hope to add a new method to these strategies.